Adverum Biotechnologies, Inc. (LON:0HA3)

Adverum Biotechnologies Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	44	78	60	48	128	774
Market Cap Growth	-70.90%	29.96%	24.48%	-62.40%	-83.52%	37.76%
Enterprise Value	79	14	27	-33	-28	464
Last Close Price	2.18	3.66	5.90	4.90	13.35	85.92
PS Ratio	60.60	97.15	21.13	-	23.03	-
PB Ratio	-3.00	1.37	1.13	0.32	0.55	2.43
P/TBV Ratio	-	1.37	1.13	0.32	0.55	2.43
EV/Sales Ratio	108.26	17.17	9.58	-	-	-
Debt / Equity Ratio	-4.56	1.30	1.10	0.59	0.33	0.07
Asset Turnover	0.01	0.01	0.02	-	0.02	-
Quick Ratio	1.42	5.49	4.83	5.76	14.58	20.59
Current Ratio	1.54	5.73	5.14	5.91	14.88	20.82
Return on Equity (ROE)	-229.34%	-189.84%	-98.19%	-62.10%	-38.78%	-38.57%
Return on Assets (ROA)	-62.55%	-51.83%	-34.73%	-25.11%	-19.66%	-20.90%
Return on Capital (ROIC)	-69.74%	-57.28%	-37.52%	-26.56%	-20.51%	-21.93%
Earnings Yield	-279.67%	-134.77%	-160.57%	-267.40%	-84.25%	-11.12%
FCF Yield	-217.03%	-95.58%	-120.59%	-207.48%	-71.17%	-8.63%
Buyback Yield / Dilution	-45.11%	-96.21%	-1.58%	-1.24%	-15.14%	-32.83%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.